Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bembi, B.
Right arrow Articles by Capus, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bembi, B.
Right arrow Articles by Capus, L.
Related Collections
Right arrow Lipidoses
Right arrow Parkinson's disease/Parkinsonism

Neurology 2003;61:99-101
© 2003 American Academy of Neurology


Brief Communications

Gaucher’s disease with Parkinson’s disease

Clinical and pathological aspects

B. Bembi, MD, S. Zambito Marsala, MD, E. Sidransky, MD, PhD, G. Ciana, MD, M. Carrozzi, MD, M. Zorzon, MD, C. Martini, MD, M. Gioulis, MD, M.G. Pittis, SD, PhD and L. Capus, MD

From Unità Operativa Dipartimentale di Malattie Metaboliche (Drs. Bembi, Ciana, Martini, and Pittis), Unità Operativa di Neuropsichiatria Infantile (Dr. Carrozzi), I.R.C.C.S. Burlo Garofolo, Trieste; Dipartimento di Medicina Clinica e Neurologia (Drs. Zambito Marsala, Zorzon, Gioulis, and Capus), Università degli Studi di Trieste, Italy; and Clinical Neuroscience Branch NIMH (Dr. Sidransky), Bethesda, MD.

Address correspondence and reprint requests to Dr. Bruno Bembi, Unità Operativa Dipartimentale di Malattie Metaboliche, Istituto di Ricerca e Cura a Crattere Scientifico "Burlo Garofolo," via dell’Istria 65/1, 34137 Trieste, Italy; e-mail: bembi{at}burlo.trieste.it

The association between type 1 Gaucher disease and PD has been reported in the literature. The clinical picture is characterized by the predominance of bilateral akinetic-rigid signs and poor response to levodopa therapy. The authors describe four patients (two siblings) with type 1 Gaucher disease presenting with the following signs of typical PD: asymmetric onset of rigidity, resting tremor, bradykinesia, and a favorable response to Parkinson therapies.




This article has been cited by other articles:


Home page
NeurologyHome page
Z. Gan-Or, N. Giladi, U. Rozovski, C. Shifrin, S. Rosner, T. Gurevich, A. Bar-Shira, and A. Orr-Urtreger
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Neurology, June 10, 2008; 70(24): 2277 - 2283.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Spitz, R Rozenberg, P A A Silveira, and E R Barbosa
Parkinsonism in type 1 Gaucher's disease
J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 709 - 710.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
O Goker-Alpan, K S Hruska, E Orvisky, P S Kishnani, B K Stubblefield, R Schiffmann, and E Sidransky
Divergent phenotypes in Gaucher disease implicate the role of modifiers
J. Med. Genet., June 1, 2005; 42(6): e37 - e37.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
O Goker-Alpan, R Schiffmann, M E LaMarca, R L Nussbaum, A McInerney-Leo, and E Sidransky
Parkinsonism among Gaucher disease carriers
J. Med. Genet., December 1, 2004; 41(12): 937 - 940.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Aharon-Peretz, H. Rosenbaum, and R. Gershoni-Baruch
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
N. Engl. J. Med., November 4, 2004; 351(19): 1972 - 1977.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. A. Wilson, D. D. Murphy, B. I. Giasson, B. Zhang, J. Q. Trojanowski, and V. M.-Y. Lee
Degradative organelles containing mislocalized {alpha}- and {beta}-synuclein proliferate in presenilin-1 null neurons
J. Cell Biol., May 10, 2004; 165(3): 335 - 346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.